THERACAN | UiT

The aim for the THERACAN project is to develop a more targeted treatment for severe cancer using radioactive substances. The project is led by UiT The Arctic University of Norway and the University Hospital of North Norway, and is funded by the Tromsø Research Foundation, the Trond Mohn Research Foundation, and the Norwegian Cancer Society. The project will run until December 2030.

Latest news

Destroying cancer cells with radioactivity

23.03.2026

UiT.no: When conventional cancer treatments are no longer effective, radioactivity may in the future offer a life-saving alternative. This is particularly good news [...]

Destroying cancer cells with radioactivity

19.03.2026

Pingvinavisa: When conventional cancer treatments are no longer effective, radioactivity may in the future offer a life-saving alternative. This is particularly good [...]

Opinion piece: More effective and precise cancer treatment is on the way

16.03.2026

Dagens Medisin: Through the THERACAN project, UiT and UNN are taking a leading role in developing the cancer treatments of the future.

40 million for promising new cancer research: “This works!”

12.03.2026

Nordlys: They all went through gruelling cancer treatments and relapses. Now, a new method could both save more lives and cause far fewer side effects.

Will use "radioactive missiles" against advanced cancer

12.03.2026

NRK: Researchers in Tromsø will test a new type of targeted radiation therapy for patients whose cancer no longer responds to other treatments.

NOK 56 million from the Tromsø Research Foundation for three UiT projects

23.05.2025

UiT.no: The foundation is this year providing funding for research and education projects focused on cancer treatment, fusion power, and interdisciplinary mathematics.

All news